Literature DB >> 23842472

Pre-existing medical conditions associated with Vibrio vulnificus septicaemia.

M P Menon1, P A Yu1, M Iwamoto1, J Painter1.   

Abstract

Vibrio vulnificus (Vv) can result in severe disease. Although pre-existing liver disease is a recognized risk factor for serious infection, the relative importance of other comorbidities has not been fully assessed. We analysed reports of Vv infections submitted to CDC from January 1988 to September 2006 in order to assess the role of pre-existing conditions contributing to severe outcomes. A total of 1212 patients with Vv infection were reported. Only patients with liver disease [adjusted odds ratio (aOR) 5.1)] were more likely to become septic when exposure was due to contaminated food. Patients with liver disease (aOR 4.1), a haematological disease (aOR 3.2), or malignancy (aOR 3.2) were more likely to become septic when infection was acquired via a non-foodborne exposure. As such, patients with these pre-existing medical conditions should be advised of the risk of life-threatening illness after eating undercooked contaminated seafood or exposing broken skin to warm seawater.

Entities:  

Mesh:

Year:  2013        PMID: 23842472      PMCID: PMC4598054          DOI: 10.1017/S0950268813001593

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

Review 1.  Epidemiology of seafood-associated infections in the United States.

Authors:  Martha Iwamoto; Tracy Ayers; Barbara E Mahon; David L Swerdlow
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 2.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

Review 3.  Vibrio vulnificus oysters: pearls and perils.

Authors:  Nicholas A Daniels
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

4.  Vibrio illnesses after Hurricane Katrina--multiple states, August-September 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-09-23       Impact factor: 17.586

5.  Halophilic Vibrio species isolated from blood cultures.

Authors:  D G Hollis; R E Weaver; C N Baker; C Thornsberry
Journal:  J Clin Microbiol       Date:  1976-04       Impact factor: 5.948

Review 6.  Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings.

Authors:  P A Tilley; F J Roberts
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

7.  Disease caused by a marine Vibrio. Clinical characteristics and epidemiology.

Authors:  P A Blake; M H Merson; R E Weaver; D G Hollis; P C Heublein
Journal:  N Engl J Med       Date:  1979-01-04       Impact factor: 91.245

8.  Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006.

Authors:  Amy M Dechet; Patricia A Yu; Nana Koram; John Painter
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

9.  Increasing rates of vibriosis in the United States, 1996-2010: review of surveillance data from 2 systems.

Authors:  Anna Newton; Magdalena Kendall; Duc J Vugia; Olga L Henao; Barbara E Mahon
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

10.  Foodborne illness acquired in the United States--major pathogens.

Authors:  Elaine Scallan; Robert M Hoekstra; Frederick J Angulo; Robert V Tauxe; Marc-Alain Widdowson; Sharon L Roy; Jeffery L Jones; Patricia M Griffin
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

View more
  12 in total

1.  Late-onset Vibrio vulnificus septicemia without cirrhosis.

Authors:  Michelle T Lee; An Q Dinh; Stephanie Nguyen; Gus Krucke; Truc T Tran
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-03-28

2.  Vibrio vulnificus biotype 3 multifunctional autoprocessing RTX toxin is an adenylate cyclase toxin essential for virulence in mice.

Authors:  Kevin J Ziolo; Hee-Gon Jeong; Jayme S Kwak; Shuangni Yang; Robert M Lavker; Karla J F Satchell
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.609

3.  Severe septicemia, necrotizing fasciitis, and peritonitis due to Vibrio vulnificus in a patient undergoing continuous ambulatory peritoneal dialysis: a case report.

Authors:  Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  BMC Infect Dis       Date:  2015-10-14       Impact factor: 3.090

4.  Immunogenicity and protective efficacy of Vibrio vulnificus flagellin protein FlaB in a wound infection model.

Authors:  Kohei Yamazaki; Takashige Kashimoto; Yuki Hashimoto; Takehiro Kado; Shunji Ueno
Journal:  J Vet Med Sci       Date:  2017-11-15       Impact factor: 1.267

5.  Skin Manifestations of Primary Vibrio vulnificus Septicemia.

Authors:  Norman L Beatty; Jose Marquez; Mayar Al Mohajer
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

6.  Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.

Authors:  Seong Eun Kim; Sung Un Shin; Tae Hoon Oh; Uh Jin Kim; Kalifa Sanneh Darboe; Seung-Ji Kang; Hee-Chang Jang; Sook-In Jung; Hee-Young Shin; Kyung-Hwa Park
Journal:  PLoS Negl Trop Dis       Date:  2019-06-12

7.  Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.

Authors:  Sonya A Trinh; Hannah E Gavin; Karla J F Satchell
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.938

8.  Distinct roles of the repeat-containing regions and effector domains of the Vibrio vulnificus multifunctional-autoprocessing repeats-in-toxin (MARTX) toxin.

Authors:  Byoung Sik Kim; Hannah E Gavin; Karla J F Satchell
Journal:  mBio       Date:  2015-03-31       Impact factor: 7.786

9.  Patterns of triclosan resistance in Vibrionaceae.

Authors:  Keri A Lydon; Megan J Robertson; Erin K Lipp
Journal:  PeerJ       Date:  2018-07-12       Impact factor: 2.984

Review 10.  Vibrio vulnificus Hemolysin: Biological Activity, Regulation of vvhA Expression, and Role in Pathogenesis.

Authors:  Yuan Yuan; Zihan Feng; Jinglin Wang
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.